These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 24898425)

  • 1. Chromosomal instability associated with global DNA hypomethylation is associated with the initiation and progression of esophageal squamous cell carcinoma.
    Kawano H; Saeki H; Kitao H; Tsuda Y; Otsu H; Ando K; Ito S; Egashira A; Oki E; Morita M; Oda Y; Maehara Y
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S696-702. PubMed ID: 24898425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINE-1 hypomethylation in noncancerous esophageal mucosae is associated with smoking history.
    Shigaki H; Baba Y; Watanabe M; Iwagami S; Miyake K; Ishimoto T; Iwatsuki M; Baba H
    Ann Surg Oncol; 2012 Dec; 19(13):4238-43. PubMed ID: 22766991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrosequencing assay to measure LINE-1 methylation level in esophageal squamous cell carcinoma.
    Iwagami S; Baba Y; Watanabe M; Shigaki H; Miyake K; Ida S; Nagai Y; Ishimoto T; Iwatsuki M; Sakamoto Y; Miyamoto Y; Baba H
    Ann Surg Oncol; 2012 Aug; 19(8):2726-32. PubMed ID: 22187122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINE-1 hypomethylation is associated with a poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
    Iwagami S; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Sakamaki K; Ohashi Y; Baba H
    Ann Surg; 2013 Mar; 257(3):449-55. PubMed ID: 23023202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation status of retinoic acid receptor beta2 promoter and global DNA in esophageal squamous cell carcinoma.
    Li RN; Yu FJ; Wu CC; Chen YK; Yu CC; Chou SH; Lee JY; Cheng YJ; Wu MT; Wu IC
    J Surg Oncol; 2014 May; 109(6):623-7. PubMed ID: 24510455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.
    Hoshimoto S; Takeuchi H; Ono S; Sim MS; Huynh JL; Huang SK; Marzese DM; Kitagawa Y; Hoon DS
    J Thorac Oncol; 2015 Mar; 10(3):509-17. PubMed ID: 25514805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINE-1 hypomethylation, DNA copy number alterations, and CDK6 amplification in esophageal squamous cell carcinoma.
    Baba Y; Watanabe M; Murata A; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Sakamaki K; Nakao M; Baba H
    Clin Cancer Res; 2014 Mar; 20(5):1114-24. PubMed ID: 24423610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma.
    Nakamura K; Baba Y; Kosumi K; Harada K; Shigaki H; Miyake K; Kiyozumi Y; Ohuchi M; Kurashige J; Ishimoto T; Iwatsuki M; Sakamoto Y; Yoshida N; Watanabe M; Nakao M; Baba H
    Oncotarget; 2016 Sep; 7(36):57821-57831. PubMed ID: 27507047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypomethylation of Alu repetitive elements in esophageal mucosa, and its potential contribution to the epigenetic field for cancerization.
    Matsuda Y; Yamashita S; Lee YC; Niwa T; Yoshida T; Gyobu K; Igaki H; Kushima R; Lee S; Wu MS; Osugi H; Suehiro S; Ushijima T
    Cancer Causes Control; 2012 Jun; 23(6):865-73. PubMed ID: 22527164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.
    Murata A; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Morita M; Nakao M; Baba H
    Ann Surg Oncol; 2014 Apr; 21(4):1166-74. PubMed ID: 24318096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Characteristics of Basaloid Squamous Cell Carcinoma of the Esophagus: Analysis of KRAS, BRAF, and PIK3CA Mutations and LINE-1 Methylation.
    Baba Y; Ishimoto T; Harada K; Kosumi K; Murata A; Miyake K; Hiyoshi Y; Kurashige J; Iwatsuki M; Iwagami S; Miyamoto Y; Sakamoto Y; Yoshida N; Oki E; Iyama K; Watanabe M; Baba H
    Ann Surg Oncol; 2015 Oct; 22(11):3659-65. PubMed ID: 25691283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of mitochondrial DNA alterations in esophageal squamous cell carcinomas.
    Lin CS; Chang SC; Wang LS; Chou TY; Hsu WH; Wu YC; Wei YH
    J Thorac Cardiovasc Surg; 2010 Jan; 139(1):189-197.e4. PubMed ID: 19660406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of MDR1 associated with Line-1 hypomethylation in esophageal squamous cell carcinoma.
    Zhu J; Ling Y; Xu Y; Lu MZ; Liu YP; Zhang CS
    Int J Clin Exp Pathol; 2015; 8(11):14392-400. PubMed ID: 26823755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage.
    Smith IM; Mydlarz WK; Mithani SK; Califano JA
    Int J Cancer; 2007 Oct; 121(8):1724-8. PubMed ID: 17582607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
    Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T
    Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
    Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOBEC3B is an enzymatic source of molecular alterations in esophageal squamous cell carcinoma.
    Kosumi K; Baba Y; Ishimoto T; Harada K; Nakamura K; Ohuchi M; Kiyozumi Y; Izumi D; Tokunaga R; Taki K; Higashi T; Miyata T; Shigaki H; Kurashige J; Hiyoshi Y; Iwatsuki M; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
    Med Oncol; 2016 Mar; 33(3):26. PubMed ID: 26880326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Old Story Retold: Loss of G1 Control Defines A Distinct Genomic Subtype of Esophageal Squamous Cell Carcinoma.
    Wang Q; Bai J; Abliz A; Liu Y; Gong K; Li J; Shi W; Pan Y; Liu F; Lai S; Yang H; Lu C; Zhang L; Chen W; Xu R; Cai H; Ke Y; Zeng C
    Genomics Proteomics Bioinformatics; 2015 Aug; 13(4):258-70. PubMed ID: 26386145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus.
    Yamada A; Fujii S; Daiko H; Nishimura M; Chiba T; Ochiai A
    Int J Oncol; 2011 Feb; 38(2):345-53. PubMed ID: 21165554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 gene alternation in squamous cell carcinoma of the esophagus detected by PCR-cold SSCP analysis.
    Wang LS; Chow KC; Liu CC; Chiu JH
    Proc Natl Sci Counc Repub China B; 1998 Jul; 22(3):114-21. PubMed ID: 9779600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.